DCC suitors given overnight extension to make a bid ahead of agm

DCC, Ireland's largest listed company, has received an extended deadline for potential takeover bids, giving bidders until 7 a.m. on Thursday to submit their proposals ahead of the company’s annual general meeting (AGM). This follows pressure from shareholders and the Irish Takeover Panel, which approved the delay to allow further negotiations between the US private equity consortium, comprising KKR and Energy Capital Partners, and DCC’s board. The move comes amid ongoing uncertainty over whether a proposed £5.7 billion ($6.67 billion) acquisition will proceed. The extension marks the third such delay granted to the consortium since the initial takeover approach was announced in late April. According to DCC, the additional time was necessary to facilitate “further discussions.” However, the company emphasized that there was still no guarantee that a formal bid would be submitted. In a statement released after European markets closed on Wednesday, DCC advised shareholders not to take any immediate action, citing the lack of clarity around the situation. The consortium’s offer, valued at £66.72 per share, represents a 15 percent increase from a previous proposal that was rejected by DCC’s board earlier this year. That earlier bid was deemed too low by the board, which argued it did not adequately reflect the company’s true value. The current offer also includes the payment of a final £1.47 dividend, which would normally be distributed to shareholders later this month, pending approval at Thursday’s AGM. Despite the increased valuation, several major shareholders have expressed skepticism about the proposed deal. Fidelity International, DCC’s largest shareholder with a 6.9 percent stake, stated earlier this month that the bid fails to capture the company’s actual worth. Aviva Investors, holding a 2.2 percent stake, and Ninety One, previously known as Investec Asset Management, have also voiced opposition to the sale at the proposed price. Jim Flavin, DCC’s founder and a minority shareholder with a 3.2 percent stake, has been vocal in his criticism of the proposed transaction. Speaking to media outlets, including The Irish Times, Flavin has urged the board to reject the offer and instead focus on executing the company’s long-term growth strategy. He called for DCC to emulate the independent trajectory taken by construction firm CRH, suggesting that the company could achieve greater success by maintaining its autonomy rather than being acquired. Flavin estimated that the current bid values DCC’s core energy operations at just 10.8 times its projected earnings for the current fiscal year, a figure he described as “ludicrous.” He argued that a more appropriate valuation of 16.5 times earnings would result in a share price of £100, significantly higher than the proposed £66.72. DCC has undergone significant restructuring in recent years, shedding its diverse portfolio of businesses. In late 2024, the company abandoned its conglomerate model by divesting its healthcare division, which was sold to private equity-backed HealthCo Investment for an enterprise value of £1.05 billion. A portion of its technology business was also sold, while the remaining segment is currently under review for possible disposal. The energy sector, which forms the backbone of DCC’s current operations, generated an operating profit of £554.2 million during the financial year ending in March. Meanwhile, the technology arm contributed £79.9 million in profits. These figures underscore the strength of DCC’s core divisions, despite the ongoing debate over the company’s future direction. As the AGM approaches, the outcome of the shareholder vote will determine whether the proposed sale moves forward. With major stakeholders divided on the issue, the decision rests heavily on the board’s ability to convince investors that the current bid aligns with the company’s interests. The final resolution will likely hinge on whether the consortium can address concerns raised by dissenting shareholders and present a compelling case for the acquisition.